Naheed L. Khan

4.9k total citations
27 papers, 1.6k citations indexed

About

Naheed L. Khan is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Naheed L. Khan has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Naheed L. Khan's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (11 papers) and Neurological diseases and metabolism (7 papers). Naheed L. Khan is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Neurological disorders and treatments (11 papers) and Neurological diseases and metabolism (7 papers). Naheed L. Khan collaborates with scholars based in United Kingdom, United States and Italy. Naheed L. Khan's co-authors include Nicholas Wood, Andrew J. Lees, Kailash P. Bhatia, Niall Quinn, Paola Piccini, David J. Brooks, Elizabeth Graham, Peter Critchley, Anette Schrag and Quentin A. Pankhurst and has published in prestigious journals such as Brain, Neurology and Annals of Neurology.

In The Last Decade

Naheed L. Khan

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naheed L. Khan United Kingdom 19 1.2k 655 381 360 303 27 1.6k
Tàmara Ialongo Italy 19 1.2k 1.0× 673 1.0× 283 0.7× 237 0.7× 360 1.2× 25 1.5k
Johann Hagenah Germany 25 1.3k 1.1× 717 1.1× 286 0.8× 264 0.7× 507 1.7× 60 2.0k
Bülent Elibol Türkiye 20 1.0k 0.8× 755 1.2× 330 0.9× 211 0.6× 501 1.7× 58 1.8k
Ana Djarmati Germany 19 845 0.7× 605 0.9× 233 0.6× 162 0.5× 499 1.6× 29 1.3k
Naoto Sugeno Japan 22 997 0.8× 431 0.7× 223 0.6× 426 1.2× 410 1.4× 54 1.6k
Hodaka Yamakado Japan 19 736 0.6× 370 0.6× 270 0.7× 343 1.0× 317 1.0× 50 1.2k
Rubén Fernández‐Santiago Spain 23 849 0.7× 372 0.6× 202 0.5× 243 0.7× 643 2.1× 46 1.5k
Niccolò E. Mencacci United Kingdom 25 1.3k 1.0× 798 1.2× 245 0.6× 426 1.2× 675 2.2× 58 2.1k
M Papp Hungary 11 1.3k 1.1× 765 1.2× 605 1.6× 417 1.2× 341 1.1× 27 1.6k
Jason P. Covy United States 12 597 0.5× 608 0.9× 268 0.7× 378 1.1× 1.0k 3.4× 14 1.8k

Countries citing papers authored by Naheed L. Khan

Since Specialization
Citations

This map shows the geographic impact of Naheed L. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naheed L. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naheed L. Khan more than expected).

Fields of papers citing papers by Naheed L. Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naheed L. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naheed L. Khan. The network helps show where Naheed L. Khan may publish in the future.

Co-authorship network of co-authors of Naheed L. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Naheed L. Khan. A scholar is included among the top collaborators of Naheed L. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naheed L. Khan. Naheed L. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pagano, Gennaro, Flavia Niccolini, Heather Wilson, et al.. (2019). Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease. Movement Disorders. 34(10). 1505–1515. 11 indexed citations
2.
Pavese, Nicola, Robert Y. Moore, Christoph Scherfler, et al.. (2010). In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study. Experimental Neurology. 222(1). 120–124. 20 indexed citations
3.
Pavese, Nicola, Naheed L. Khan, Christoph Scherfler, et al.. (2009). Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: An 18F‐dopa PET progression study. Movement Disorders. 24(15). 2260–2266. 39 indexed citations
4.
Schneider, Susanne A., Penelope Talelli, Binith Cheeran, et al.. (2008). Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations. Movement Disorders. 23(13). 1812–1819. 29 indexed citations
5.
Scherfler, Christoph, Naheed L. Khan, Nicola Pavese, et al.. (2006). Upregulation of dopamine D2 receptors in dopaminergic drug‐naive patients with parkin gene mutations. Movement Disorders. 21(6). 783–788. 29 indexed citations
6.
Khan, Naheed L., L. H. Eunson, Elizabeth Graham, et al.. (2005). Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow‐up over 10 years. Movement Disorders. 20(4). 479–484. 27 indexed citations
7.
Khan, Naheed L., Paola Giunti, Mary G. Sweeney, et al.. (2005). Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Movement Disorders. 20(9). 1115–1119. 34 indexed citations
8.
Scherfler, Christoph, Naheed L. Khan, Joseph V. Hajnal, et al.. (2005). Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and parkin‐linked Parkinson's disease. Movement Disorders. 21(3). 299–305. 18 indexed citations
9.
Clarimón, Jordi, Janel Johnson, Okan Doğu, et al.. (2005). Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 133B(1). 120–123. 18 indexed citations
10.
Josephs, Keith A., Janice L. Holton, Martin N. Rossor, et al.. (2004). Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathology and Applied Neurobiology. 30(4). 369–373. 125 indexed citations
11.
Lashley, Tammaryn, Graham Gibb, Diane P. Hanger, et al.. (2003). Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathology and Applied Neurobiology. 29(3). 288–302. 175 indexed citations
12.
Khan, Naheed L., Nicholas Wood, & Kailash P. Bhatia. (2003). Autosomal recessive, DYT2-like primary torsion dystonia. Neurology. 61(12). 1801–1803. 29 indexed citations
13.
Khan, Naheed L., Enza Maria Valente, Anna Rita Bentivoglio, et al.. (2002). Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study. Annals of Neurology. 52(6). 849–853. 156 indexed citations
14.
Nicholl, David, Jenny Vaughan, Naheed L. Khan, et al.. (2002). Two large British kindreds with familial Parkinson’s disease: a clinico‐pathological and genetic study. Brain. 125(1). 44–57. 18 indexed citations
15.
Khan, Naheed L.. (2002). Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain. 125(10). 2248–2256. 132 indexed citations
16.
Silva, Rohan de, John Hardy, Julia E. Crook, et al.. (2002). The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease. Neuroscience Letters. 330(2). 201–203. 34 indexed citations
17.
Bandopadhyay, Rina, Rohan de Silva, Naheed L. Khan, et al.. (2001). No pathogenic mutations in the synphilin-1 gene in Parkinson's disease. Neuroscience Letters. 307(2). 125–127. 13 indexed citations
18.
Khan, Naheed L., Elizabeth Graham, Peter Dixon, et al.. (2001). Parkinson's disease is not associated with the combined α‐synuclein/apolipoprotein E susceptibility genotype. Annals of Neurology. 49(5). 665–668. 53 indexed citations
19.
Khan, Naheed L. & Nicholas Wood. (1999). Prader-Willi and Angelman syndromes: update on genetic mechanisms and diagnostic complexities. Current Opinion in Neurology. 12(2). 149–154. 15 indexed citations
20.
Ward, Frank J., et al.. (1998). Immunogenic Properties of an Anti-DNA Antibody- Derived Peptide, 88H.64-80: Location of a Dominant Idiotope Defined by T and B Cells. Journal of Autoimmunity. 11(5). 439–447. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tàmara Ialongo Breakdown of academic impact, for papers by Johann Hagenah Breakdown of academic impact, for papers by Bülent Elibol Breakdown of academic impact, for papers by Ana Djarmati Breakdown of academic impact, for papers by Naoto Sugeno Breakdown of academic impact, for papers by Hodaka Yamakado Breakdown of academic impact, for papers by Rubén Fernández‐Santiago Breakdown of academic impact, for papers by Niccolò E. Mencacci Breakdown of academic impact, for papers by M Papp Breakdown of academic impact, for papers by Jason P. Covy
Rankless by CCL
2026